What a Mindbloom Affiliated Study Can and Cannot Tell Us About At-Home Ketamine Injections
A study reports symptom improvement among patients in Mindbloom’s at-home ketamine injections. However, this was not an independent test.
Read Morelisteo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170
A study reports symptom improvement among patients in Mindbloom’s at-home ketamine injections. However, this was not an independent test.
Read More
Ketamine can reduce pain while producing an altered sense of self. A new study suggests they may travel along separate biological paths.
Read More
The FDA finalized its first formal guidance for studying psychedelic drugs. The document sets the ground rules for research into psilocybin, LSD, and MDMA.
Read More
A German company may have moved oral ketamine one step closer to the home. The prolonged release capsule produced fast antidepressant effects.
Read More
Can MDMA assisted therapy safely help veterans living with both PTSD and alcohol use disorder? The VA Hopes to find out.
Read More
A new review in Hearing Research suggests psilocybin may one day help researchers target tinnitus in a different way.
Read More
Intravenous ketamine reduced suicidal and depressive symptoms quickly, sometimes within hours. That matters.
Read More
A new narrative review argues that ketamine dosing should be rethought. An anesthesia dose, a pain dose and a psychiatric dose are not equal.
Read More
One of the country’s most influential anesthesia groups is warning that ketamine telehealth's safety standards have not kept pace.
Read More
Ketamine is often described through one clean mechanism. But a new study shows the science behind its effects may be broader than we thought.
Read More